Pharmacovigilance Platform Integrating Automated Document Generation and Risk Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current pharmacovigilance systems focus primarily on safety reporting rather than comprehensive medical monitoring and management, lacking efficient tools for data analysis and visualization to detect and mitigate treatment-related adverse events effectively.

Innovation Solution

A digital storage medium and computer program product that provides automated document generation, risk analysis, interactive graphs, Burden of Therapy (BOTh) graphs, proactive warning signals, and safety information management to enhance pharmacovigilance monitoring and medical review, utilizing a cloud-based infrastructure for secure and efficient data processing and visualization.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional pharmacovigilance systems focus on safety reporting, then regulatory compliance is maintained, but comprehensive medical monitoring and management capabilities are insufficient

Engineering Contradiction:
Improvesafety reporting complianceVSAvoidmedical monitoring capability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The system integrates multiple functions including automated document generation, risk analysis, interactive graphing, and safety information management into a single pharmacovigilance platform. This multi-functional approach allows the system to maintain regulatory compliance while simultaneously providing comprehensive medical monitoring and management capabilities, resolving the contradiction between specialized safety reporting and versatile medical monitoring.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent combines previously separate functions (safety reporting, medical monitoring, data analysis, and documentation) into an integrated system. By merging these functions, the system achieves both reliable regulatory reporting and adaptable medical monitoring capabilities within a unified platform.

Inventive Principle:
Principle #5Merging (Combining)

2Device complexity

If manual data analysis methods are used, then implementation simplicity is maintained, but efficiency and effectiveness of detecting treatment-related adverse events are insufficient

Engineering Contradiction:
Improvesystem simplicityVSAvoiddata analysis efficiency
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The system incorporates automated document generation and self-updating risk analysis features that reduce manual intervention. The automated generation of pharmacovigilance documents and dynamic risk assessments enables the system to perform complex analyses without proportionally increasing operational complexity, thereby improving productivity while maintaining ease of use.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent replaces manual mechanical data analysis processes with automated computational systems. Interactive graphs, automated risk calculations, and algorithm-driven adverse event detection substitute for manual review methods, significantly improving data analysis efficiency while the user-friendly interface maintains system simplicity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Measurement precision

If comprehensive safety data monitoring is implemented, then patient safety detection capability is improved, but system complexity and resource requirements increase

Engineering Contradiction:
Improvesafety issue detection accuracyVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system segments comprehensive safety data into organized categories and domains, presenting them through structured interactive graphs and risk analysis frameworks. This segmentation allows the system to process and monitor extensive safety data with high precision while maintaining manageable system complexity through organized data structures and modular analysis components.

Inventive Principle:
Principle #1Segmentation

4Productivity

If automated document generation is provided, then productivity and regulatory compliance efficiency are improved, but device complexity increases

Engineering Contradiction:
Improvedocument generation efficiencyVSAvoidautomation system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The automated document generation system uses templates and standardized formats to create pharmacovigilance documents. By copying proven document structures and applying automated data population, the system achieves high productivity and regulatory compliance efficiency while keeping the automation logic relatively simple and maintainable.

Inventive Principle:
Principle #26Copying

Data Source

PatentEP4481750A1Pharmacovigilance monitoring and medical review method
Publication Date: 2024.12.25 BOTH ANALYTICS GMBH
  • EP4481750A1 patent drawingFigure 1
  • EP4481750A1 patent drawingFigure 2
  • EP4481750A1 patent drawingFigure 3

AI summary

The invention comprises a method for pharmacovigilance monitoring and medical review according to the invention. The method comprises providing automated generation and/or management of study documents, providing risk analysis of patient safety, providing interactive graphs for main safety domains, providing in-depth study overviews, providing clickable statistical graphs, providing Burden of Therapy (BOTh) graphs, providing proactive warning signals and/or providing safety information management. The invention further comprises a digital storage medium, a computer program product and a computer program for executing the method.